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ABSTRACT
MENTAL ILLNESS IN THE US
Mental illness treatment in the United States has developed and
changed drastically in the past century. Where in the early 1900s,
one with a severe mental illness would be institutionalized, today,
the same person could be treated with psychotherapy and
medications.
Pharmacists are the modern bridge to aid those with mental illness
to live on their own and contribute to society.
Figure 1a. Twenty 
percent of Americans 
experience a mental 
illness.  About 2.4 
million live with 
schizophrenia in the 
United States. Half of 
all chronic illnesses 
begin by the age of 
14[1].
HISTORY OF ANTIPSYCHOTICS
Antipsychotic medications were found through the efforts to
synthesize antimalarial drugs during WWI and WWII.
Antihistamines that were manufactured at this time were found to
be “agent[s] to potentiate anesthesia”[3]. These effects were
desirable in being able to sedate those with severe psychosis or
having psychotic episodes. A majority of funding for antipsychotic
medications comes from private industrial support instead of public
research organizations.
Antipsychotic medication development started with the fortunate
mistake of synthesizing chlorpromazine followed shortly by most of
the typical antipsychotic drugs. The introduction of clozapine in
1990 changed the face of schizophrenic treatments and opened the
gateway for atypical antipsychotic drugs with little to no
extrapyramidal symptoms.
CLASSES OF ANTIPSYCHOTICS
Antipsychotic medications are divided into two different classes
based on when they were released and the extrapyramidal
symptoms (EPS) that accompany the drug. Classes include typical
and atypical. Within the “typical” class are low potency and high
potency drugs. The difference between typical and atypical drugs
have to do with their extrapyramidal symptoms (EPS) and when
they were first released for use to the public.
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Figure 1b. More than 10 
million adults live with a 
mental illness while also 
battling substance 
addiction.  Serious 
mental illness costs the 
US $193.2 billion in lost 
earning every year[1]. 
Figure 3. This chart shows typical and atypical medications in addition to their known
EPS and their severities. [4]






Retail pharmacists are responsible for counseling patients, helping
with medication management and preventative care screenings.
They strive to educate patients on proper use of medication and
potential drug interactions. [5]
Due to deinstitutionalization campaigns in the 1900s, there has been
a drastic increase in research for a chemical “restraint” for those
with mental illness[2]. The stigma for mental illness in the US has
slightly improved but the varied availability of medications and
outpatient therapy has made the common person more comfortable
with seeking help when experiencing mental illness.
Figure 4. CVS manages 
more than 1.9 billion 
prescriptions annually and 
more than 5 million 
customers every day.
Properly diagnosed schizophrenia can be managed with 
medication and psychotherapy.  With mental disorder diagnoses 
on the rise, pharmacist are instrumental in aiding the general 
population with information and care so they can independently 
manage their illnesses.
PHARMACISTS AND THEIR ROLE
RETAIL PHARMACY AND MENTAL ILLNESS
“Pharmacists help fill the gaps in patient care by 
educating patients, monitoring medications, and 
administering injections prescribed by other 
health care professionals” [6].  
Figure 2. Clozapine
